Deadline for submitting a clinical trial application (CTA) in 2015 is 11 December.
The Icelandic Medicines Agency will be closed Friday 25 September, due to an annual Out-of-office Workshop by staff.
Referral Art. 31, EMEA/H/A-31/1400 regarding Hydroxyzine hydrochloride/Atarax is finished
- Receipt of clinical trial applications (CTA) summer 2015
- The Icelandic Medicines Agency (IMA) introduces electronic signatures
- New Executive Director of IMA